Glomerular filtration apparatus

The **glomerular filtration apparatus**—commonly referred to as the glomerular filtration barrier (GFB)—is not a single molecule or canonical therapeutic target but rather a highly specialized multi-component structure within the renal glomerulus that allows selective filtration of blood. It consists of three primary layers: (1) fenestrated glomerular endothelial cells with a negatively charged glycocalyx, (2) the glomerular basement membrane (composed mainly of type IV collagen, laminin, agrin, and nidogen proteins), and (3) epithelial podocytes, whose interdigitating foot processes form slit diaphragms rich in proteins such as nephrin and podocin[1][2][3][4][6][8][9]. This apparatus allows water, small solutes, and some mid-sized solutes to be filtered from the blood while largely denying passage to most proteins and cellular elements, preserving plasma protein levels and preventing proteinuria[1][7][10]. Disruption or injury to any component of the glomerular filtration barrier causes increased permeability and is a central pathogenic mechanism in several kidney diseases including nephrotic syndrome and Alport syndrome[1][2][4]. Although the barrier is a critical structure in kidney physiology and pathology, it is not considered a single molecular target for current drug therapies; rather, individual protein components (such as nephrin or podocin) are targets for research, biomarker studies, and potential future interventions[9].

Other names

Glomerular filtration barrierGlomerular filtration assemblyGFB